About the OSU College of Pharmacy: The College of Pharmacy prepares students of today to be the pharmacy practitioners and pharmaceutical sciences researchers of tomorrow by contributing to improved health, advancing patient care and the discovery and understanding of medicines.

Oregon State research reveals how key diabetes drug is made in nature

CORVALLIS, Ore. – Research by Oregon State University has explained how an important type 2 diabetes drug is made in nature, opening the door to improvements in manufacturing through biotechnology.

Oregon State research sheds light on why not all obese patients develop type 2 diabetes

PORTLAND, Ore. – Researchers at Oregon State University have invented a new analytical method that sheds light on an enduring mystery regarding type 2 diabetes: Why some obese patients develop the disease and others don’t.

Oregon State University research finds solution to common surgical problem of nerve damage

PORTLAND, Ore. – A research collaboration including scientists from Oregon State University has developed a new technology to help surgeons know where a patient’s nerves are, lessening the chance of nerve damage.

Oregon State University research pushes closer to new therapy for pancreatic cancer

PORTLAND, Ore. – Research by Oregon State University has uncovered a potential new therapy for pancreatic cancer, whose survival rate is among the lowest of all malignancies.

For cancer patients on immunotherapy, harmful gut bacteria might matter more than helpful ones

CORVALLIS, Ore. – Melanoma patients receiving therapy that helps their immune system kill cancer cells respond to treatment differently depending on the types of microbes in their gut, and new research suggests the microorganisms hindering therapy have more influence than the beneficial ones.

Efforts to reduce opioid prescriptions may be hindering end-of-life pain management

PORTLAND, Ore. – Policies designed to prevent the misuse of opioids may have the unintended side effect of limiting access to the pain-relieving drugs by terminally ill patients nearing the end of their life, new research led by the Oregon State University College of Pharmacy suggests.

Melanoma patients respond to immunotherapy after changes to gut microbiome

CORVALLIS, Ore. – Statistical modeling developed by Oregon State University researchers has confirmed that changes to melanoma patients’ gut microbiome led them to respond to a type of treatment capable of providing long-term benefit.

Oregon State study finds room for improvement when hospital patients transition to hospice care

PORTLAND, Ore. – Terminally ill patients referred to hospice care from a hospital setting tend to be on hospice for shorter periods than those who enter hospice while living at home or in a residential care facility.

Older adults risk ER visits when dentists prescribe opioids on top of other meds, study finds

When dentists prescribe opioid painkillers to older patients who are already taking medication for depression or anxiety, the combination of drugs increases patients’ risk of landing in the emergency room and being hospitalized, according to a recent Oregon State University study.

Study points out opioid risks for hospital patients transitioning to skilled nursing facilities

PORTLAND, Ore. – Hospital patients discharged to skilled nursing facilities often bring a high-dose painkiller prescription with them, suggesting more attention should be paid to opioid safety for those patients, research from the Oregon State University College of Pharmacy shows.

Pages